Oral transmucosal fentanyl citrate as breakthrough pain relieving medication: A pilot study

ABSTRACT Background: Breakthrough pain in cancer patients is a common and distressing symptom that significantly impacts their quality of life. Traditional pain management strategies often fail to provide adequate relief. Oral transmucosal fentanyl citrate (OTFC) has emerged as a rapid-onset opioid...

Full description

Saved in:
Bibliographic Details
Published inCurrent medicine research and practice Vol. 14; no. 4; pp. 145 - 149
Main Authors Dua, Naresh, Annaram, Randheer Kumar, Jain, Pradeep, Yadav, Priya, Dua, Shubh, Sood, Jayashree
Format Journal Article
LanguageEnglish
Published Medknow Publications and Media Pvt. Ltd 01.07.2024
Wolters Kluwer Medknow Publications
Subjects
Online AccessGet full text

Cover

Loading…